Did the Clinical Spectrum of Thromboangiitis Obliterans Change in the Past 40 Years?

Author:

Soudet Simon1ORCID,Le Joncour Alexandre234,Quemeneur Thomas5,Maillard Helene1,Koskas Fabien6,Hachulla Eric1,Cacoub Patrice234,Yelnik Cecile M.1ORCID,Saadoun David234,Lambert Marc1

Affiliation:

1. Department of Internal Medicine, Hôpital HURIEZ, CHRU Lille, France

2. Department of Internal Medicine and Clinical Immunology, Centre de Référence des Maladies Auto-Immunes et Systémiques Rares, des Maladies Auto-Inflammatoires et de l’Amylose, Paris, France

3. AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France

4. Sorbonne Université, UPMC Univ Paris 06, UMR 7211, France

5. Department of Nephrology and Internal Medicine, Valenciennes Hospital, France

6. Department of Vascular Surgery, Assistance Publique des Hôpitaux de Paris, Hôpital Pitié Salpêtrière, Paris, France

Abstract

Thromboangiitis obliterans (TAO) is an inflammatory disease that usually affects small and medium-sized arteries in the upper and lower limbs of young smokers. Previous studies showed that the spectrum TAO has changed in the 80s: the male-to-female ratio decreased, older patients were diagnosed, and upper limb involvement was more common. The aim of our study was to assess the changing clinical spectrum of TAO in France during the past 40 years. All consecutive patients fulfilling TAO’s criteria between January 1967 and January 2016 were retrospectively included in 3 departments of internal medicine. We compared TAO features in patients diagnosed before and after 2002; 141 (77.5%) men and 41 (22.5%) women were included. Patients diagnosed after 2002 were older (37 [31-39] vs 34 [29-35] years P = .03), had a more frequent isolated upper limb involvement (34.3% vs 7.8% P = .001), and less frequent isolated lower limb involvement (55.7% vs 74.5%, P < .001). The clinical spectrum of TAO has changed in France since the beginning of the 21st century.

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3